Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.

We spoke with many of our current and former scientists, who shared details from their time here and some of the Institute's lasting contributions to science.

Reflecting on her time at the Institute, Dame Kay Davies said:

It was very supportive, everyone was highly competitive but very friendly. It was just a great community of people.

Some of the highlights mentioned in the video include Professor Angela Vincent's work on the role of the immune system in neurological diseases, the development of prenatal diagnosis for genetic diseases (particularly thalassemia and sickle cell disease) and Sir Peter Ratcliffe's Nobel Prize-winning research on oxygen sensing.

 

The WIMM started me off and it's starting that's the most important thing in science.

- Professor Sir Peter Ratcliffe, Nobel Prize Laureate (2019, Physiology or Medicine)

 

Learn more from our interactive timeline:

MRC WIMM Interactive Timeline

Accessible Version of the MRC WIMM Timeline.

Similar stories

New bone marrow model offers scalable platform for next-generation drug discovery

Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long-term blood and immune cell production in a fully human 3D system.